SCOPUS 정보 검색 플랫폼

Journal of Biological Inorganic Chemistry

Volumn 16, Issue 8, 2011, Pages 1205-1215

Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019

(7) Bartel, Caroline a Egger, Alexander E a Jakupec, Michael A a Heffeter, Petra b,c Galanski, Markus a Berger, Walter b,c Keppler, Bernhard K a

a UNIVERSITY OF VIENNA (Austria)

b MEDICAL UNIVERSITY OF VIENNA (Austria)

c MEDICAL UNIVERSITY OF VIENNA (Austria)

Author keywords

Anticancer; Ascorbic acid; DNA interaction; Drug uptake; Ruthenium

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; DNA; INDAZOLIUM TETRACHLOROBIS(INDAZOLE)RUTHENATE; INDAZOLIUM TRANS[TETRACHLOROBIS(1H INDAZOLE)RUTHENATE]; PLASMID DNA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL LINE; CELL PROTECTION; CELL SPECIFICITY; CELL STRAIN KB 3 1; CELL STRAIN KBC 1; CELL STRAIN SW480; CELL TRANSPORT; COLON CARCINOMA; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA CONFORMATION; DRUG CYTOTOXICITY; DRUG DNA INTERACTION; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG UPTAKE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INCUBATION TIME; MASS SPECTROMETRY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REDUCTION; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; ASCORBIC ACID; CELL SURVIVAL; DNA; DRUG SYNERGISM; DRUGS, INVESTIGATIONAL; HUMANS; INDAZOLES; KB CELLS; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOMETALLIC COMPOUNDS; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; RUTHENIUM; TUMOR CELLS, CULTURED;

EID: 84655163934 PISSN: 09498257 EISSN: 14321327 Source Type: Journal
DOI: 10.1007/s00775-011-0809-4 Document Type: Article

Times cited : (20)

References (43)

1
- 0042948708
- 10.1016/S0010-8545(02)00312-0 1:CAS:528:DC%2BD3sXkvVyqtw%3D%3D
- MJ Clarke 2003 Coord Chem Rev 236 209 233 10.1016/S0010-8545(02)00312-0 1:CAS:528:DC%2BD3sXkvVyqtw%3D%3D
- (2003) Coord Chem Rev , vol.236 , pp. 209-233
- Clarke, M.J.¹

2
- 10844269461
- Ruthenium antimetastatic agents
- DOI 10.2174/1568026043387421
- E Alessio G Mestroni A Bergamo G Sava 2004 Curr Topics Med Chem 4 1525 1535 10.2174/1568026043387421 1:CAS:528:DC%2BD2cXhtVKmsbrP (Pubitemid 39662663)
- (2004) Current Topics in Medicinal Chemistry , vol.4 , Issue.15 , pp. 1525-1535
- Alessio, E.¹ Mestroni, G.² Bergamo, A.³ Sava, G.⁴

3
- 0038327639
- 12738748 1:CAS:528:DC%2BD3sXjsFeitb8%3D
- G Sava S Zorzet C Turrin F Vita M Soranzo G Zabucchi M Cocchietto A Bergamo S DiGiovine G Pezzoni L Sartor S Garbisa 2003 Clin Cancer Res 9 1898 1905 12738748 1:CAS:528:DC%2BD3sXjsFeitb8%3D
- (2003) Clin Cancer Res , vol.9 , pp. 1898-1905
- Sava, G.¹ Zorzet, S.² Turrin, C.³ Vita, F.⁴ Soranzo, M.⁵ Zabucchi, G.⁶ Cocchietto, M.⁷ Bergamo, A.⁸ Digiovine, S.⁹ Pezzoni, G.¹⁰ Sartor, L.¹¹ Garbisa, S.¹²

4
- 33745384809
- From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
- DOI 10.1016/j.jinorgbio.2006.02.013, PII S0162013406000754
- CG Hartinger S Zorbas-Seifried MA Jakupec B Kynast H Zorbas BK Keppler 2006 J Inorg Biochem 100 891 904 16603249 10.1016/j.jinorgbio.2006.02.013 1:CAS:528:DC%2BD28XksVCluro%3D (Pubitemid 44308176)
- (2006) Journal of Inorganic Biochemistry , vol.100 , Issue.5-6 , pp. 891-904
- Hartinger, C.G.¹ Zorbas-Seifried, S.² Jakupec, M.A.³ Kynast, B.⁴ Zorbas, H.⁵ Keppler, B.K.⁶

5
- 0141811013
- Recent developments in the field of tumor-inhibiting metal complexes
- DOI 10.2174/1381612033454180
- M Galanski VB Arion MA Jakupec BK Keppler 2003 Curr Pharm Des 9 2078 2089 14529417 10.2174/1381612033454180 1:CAS:528:DC%2BD3sXnsV2gu7c%3D (Pubitemid 37142439)
- (2003) Current Pharmaceutical Design , vol.9 , Issue.25 , pp. 2078-2089
- Galanski, M.¹ Arion, V.B.² Jakupec, M.A.³ Keppler, B.K.⁴

6
- 79960419089
- doi: 10.1089/ars.2010.3663
- Jungwirth U, Kowol CR, Keppler BK, Hartinger CG, Berger W, Heffeter P (2011) Antioxid Redox Signal. doi: 10.1089/ars.2010.3663
- (2011) Antioxid Redox Signal.
- Jungwirth, U.¹ Kowol, C.R.² Keppler, B.K.³ Hartinger, C.G.⁴ Berger, W.⁵ Heffeter, P.⁶

7
- 0037081748
- 11853951 1:CAS:528:DC%2BD38Xjt1Kgsrw%3D
- O Arrigoni MC De Tullio 2002 Biochim Biophys Acta 1569 1 9 11853951 1:CAS:528:DC%2BD38Xjt1Kgsrw%3D
- (2002) Biochim Biophys Acta , vol.1569 , pp. 1-9
- Arrigoni, O.¹ De Tullio, M.C.²

8
- 7444254089
- 15500346 10.1021/ic049479c 1:CAS:528:DC%2BD2cXns12rt7s%3D
- E Reisner VB Arion MFC Guedes da Silva R Lichtenecker A Eichinger BK Keppler VY Kukushkin AJL Pombeiro 2004 Inorg Chem 43 7083 7093 15500346 10.1021/ic049479c 1:CAS:528:DC%2BD2cXns12rt7s%3D
- (2004) Inorg Chem , vol.43 , pp. 7083-7093
- Reisner, E.¹ Arion, V.B.² Guedes Da Silva, M.F.C.³ Lichtenecker, R.⁴ Eichinger, A.⁵ Keppler, B.K.⁶ Kukushkin, V.Y.⁷ Pombeiro, A.J.L.⁸

9
- 13244250963
- Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
- DOI 10.1007/s00432-004-0617-0
- S Kapitza M Pongratz MA Jakupec P Heffeter W Berger L Lackinger BK Keppler B Marian 2005 J Cancer Res Clin Oncol 131 101 110 15503135 10.1007/s00432-004-0617-0 1:CAS:528:DC%2BD2MXntF2lsA%3D%3D (Pubitemid 40192935)
- (2005) Journal of Cancer Research and Clinical Oncology , vol.131 , Issue.2 , pp. 101-110
- Kapitza, S.¹ Pongratz, M.² Jakupec, M.A.³ Heffeter, P.⁴ Berger, W.⁵ Lackinger, L.⁶ Keppler, B.K.⁷ Marian, B.⁸

10
- 22844452813
- The heterocyclic ruthenium(III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells
- DOI 10.1016/j.canlet.2005.01.002, PII S0304383505000340
- S Kapitza MA Jakupec M Uhl BK Keppler B Marian 2005 Cancer Lett 226 115 121 16039951 10.1016/j.canlet.2005.01.002 1:CAS:528:DC%2BD2MXmsVaisbk%3D (Pubitemid 41039079)
- (2005) Cancer Letters , vol.226 , Issue.2 , pp. 115-121
- Kapitza, S.¹ Jakupec, M.A.² Uhl, M.³ Keppler, B.K.⁴ Marian, B.⁵

11
- 33747773739
- DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity
- DOI 10.1016/j.drup.2006.05.002, PII S1368764606000252
- V Brabec O Novakova 2006 Drug Resist Updat 9 111 122 16790363 10.1016/j.drup.2006.05.002 1:CAS:528:DC%2BD28XoslOgur4%3D (Pubitemid 44279519)
- (2006) Drug Resistance Updates , vol.9 , Issue.3 , pp. 111-122
- Brabec, V.¹ Novakova, O.²

12
- 0034956092
- 10.1007/BF02703651 1:CAS:528:DC%2BD3MXlsVOkurs%3D
- YNV Gopal AK Kondapi 2001 J Biosci 26 271 276 10.1007/BF02703651 1:CAS:528:DC%2BD3MXlsVOkurs%3D
- (2001) J Biosci , vol.26 , pp. 271-276
- Gopal, Y.N.V.¹ Kondapi, A.K.²

13
- 26444521256
- Pharamacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissuse
- DOI 10.1073/pnas.0506390102
- Q Chen MG Espey MC Krishna JB Mitchell CP Corpe GR Buettner E Shacter M Levine 2005 Proc Natl Acad Sci USA 102 13604 13609 16157892 10.1073/pnas. 0506390102 1:CAS:528:DC%2BD2MXhtVygtr%2FP (Pubitemid 41420895)
- (2005) Proceedings of the National Academy of Sciences of the United States of America , vol.102 , Issue.38 , pp. 13604-13609
- Chen, Q.¹ Espey, M.G.² Krishna, M.C.³ Mitchell, J.B.⁴ Corpe, C.P.⁵ Buettner, G.R.⁶ Shaded, E.⁷ Levine, M.⁸

14
- 34547429599
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo
- DOI 10.1073/pnas.0702854104
- Q Chen MG Espey AY Sun J-H Lee MC Krishna E Shacter PL Choyke C Pooput KL Kirk GR Buettner M Levine 2007 Proc Natl Acad Sci USA 104 8749 8754 17502596 10.1073/pnas.0702854104 1:CAS:528:DC%2BD2sXmt1aktbo%3D (Pubitemid 47175383)
- (2007) Proceedings of the National Academy of Sciences of the United States of America , vol.104 , Issue.21 , pp. 8749-8754
- Chen, Q.¹ Espey, M.G.² Sun, A.Y.³ Lee, J.-H.⁴ Krishna, M.C.⁵ Shacter, E.⁶ Choyke, P.L.⁷ Pooput, C.⁸ Kirk, K.L.⁹ Buettner, G.R.¹⁰ Levine, M.¹¹

15
- 49649115940
- 18678913 10.1073/pnas.0804226105 1:CAS:528:DC%2BD1cXhtVSnsLzF
- Q Chen MG Espey AY Sun C Pooput KL Kirk MC Krishna DB Khosh J Drisko M Leven 2008 Proc Natl Acad Sci USA 105 11105 11109 18678913 10.1073/pnas. 0804226105 1:CAS:528:DC%2BD1cXhtVSnsLzF
- (2008) Proc Natl Acad Sci USA , vol.105 , pp. 11105-11109
- Chen, Q.¹ Espey, M.G.² Sun, A.Y.³ Pooput, C.⁴ Kirk, K.L.⁵ Krishna, M.C.⁶ Khosh, D.B.⁷ Drisko, J.⁸ Leven, M.⁹

16
- 0030988524
- 9151141 1:CAS:528:DyaK2sXjvVOmsr0%3D
- TD Oberley LW Oberley 1997 Histol Histopathol 12 525 535 9151141 1:CAS:528:DyaK2sXjvVOmsr0%3D
- (1997) Histol Histopathol , vol.12 , pp. 525-535
- Oberley, T.D.¹ Oberley, L.W.²

17
- 54949089044
- 18544557 10.1093/annonc/mdn377 1:STN:280:DC%2BD1cnosVClsA%3D%3D
- LJ Hoffer M Levine S Assouline D Melnychuk SJ Padayatty K Rosadiuk C Rousseau L Robitaille WH Miller Jr 2008 Ann Oncol 19 1969 1974 18544557 10.1093/annonc/mdn377 1:STN:280:DC%2BD1cnosVClsA%3D%3D
- (2008) Ann Oncol , vol.19 , pp. 1969-1974
- Hoffer, L.J.¹ Levine, M.² Assouline, S.³ Melnychuk, D.⁴ Padayatty, S.J.⁵ Rosadiuk, K.⁶ Rousseau, C.⁷ Robitaille, L.⁸ Miller Jr., W.H.⁹

18
- 0021955675
- 10.1056/nejm198501173120301 3880867 10.1056/NEJM198501173120301 1:STN:280:DyaL2M%2Fos1WgtQ%3D%3D
- CG Moertel TR Fleming ET Creagan J Rubin MJ O'Connell MM Ames 1985 N Engl J Med 312 137 141 10.1056/nejm198501173120301 3880867 10.1056/ NEJM198501173120301 1:STN:280:DyaL2M%2Fos1WgtQ%3D%3D
- (1985) N Engl J Med , vol.312 , pp. 137-141
- Moertel, C.G.¹ Fleming, T.R.² Creagan, E.T.³ Rubin, J.⁴ O'Connell, M.J.⁵ Ames, M.M.⁶

19
- 9244219627
- Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance
- DOI 10.1073/pnas.93.8.3704
- M Levine C Conry-Cantilena Y Wang RW Welch PW Washiko KR Dhariwal JB Park A Lazarev JF Graumlich, et al. 1996 Proc Natl Acad Sci USA 93 3704 3709 8623000 10.1073/pnas.93.8.3704 1:CAS:528:DyaK28XisVWiu7Y%3D (Pubitemid 26125678)
- (1996) Proceedings of the National Academy of Sciences of the United States of America , vol.93 , Issue.8 , pp. 3704-3709
- Levine, M.¹ Conry-Cantilena, C.² Wang, Y.³ Welch, R.W.⁴ Washko, P.W.⁵ Dhariwal, K.R.⁶ Park, J.B.⁷ Lazarev, A.⁸ Graumlich, J.F.⁹ King, J.¹⁰ Cantilena, L.R.¹¹

20
- 0028925925
- 7609676 10.1016/0306-9877(95)90137-X 1:CAS:528:DyaK2MXmt1Kqurg%3D
- NH Riordan HD Riordan X Meng Y Li JA Jackson 1995 Med Hypotheses 44 207 213 7609676 10.1016/0306-9877(95)90137-X 1:CAS:528:DyaK2MXmt1Kqurg%3D
- (1995) Med Hypotheses , vol.44 , pp. 207-213
- Riordan, N.H.¹ Riordan, H.D.² Meng, X.³ Li, Y.⁴ Jackson, J.A.⁵

21
- 49649109597
- 18682554 10.1073/pnas.0806433105 1:CAS:528:DC%2BD1cXhtVSnsL%2FJ
- B Frei S Lawson 2008 Proc Natl Acad Sci USA 105 11037 11038 18682554 10.1073/pnas.0806433105 1:CAS:528:DC%2BD1cXhtVSnsL%2FJ
- (2008) Proc Natl Acad Sci USA , vol.105 , pp. 11037-11038
- Frei, B.¹ Lawson, S.²

22
- 64949179184
- 19414313 1:CAS:528:DC%2BD1MXltlOqsLc%3D
- S Ohno Y Ohno N Suzuki G-I Soma M Inoue 2009 Anticancer Res 29 809 815 19414313 1:CAS:528:DC%2BD1MXltlOqsLc%3D
- (2009) Anticancer Res , vol.29 , pp. 809-815
- Ohno, S.¹ Ohno, Y.² Suzuki, N.³ Soma, G.-I.⁴ Inoue, M.⁵

23
- 54249098684
- 18829561 10.1158/0008-5472.CAN-08-1490 1:CAS:528:DC%2BD1cXhtF2msLrL
- ML Heaney JR Gardner N Karasavvas DW Golde DA Scheinberg EA Smith OA O'Connor 2008 Cancer Res 68 8031 8038 18829561 10.1158/0008-5472.CAN-08-1490 1:CAS:528:DC%2BD1cXhtF2msLrL
- (2008) Cancer Res , vol.68 , pp. 8031-8038
- Heaney, M.L.¹ Gardner, J.R.² Karasavvas, N.³ Golde, D.W.⁴ Scheinberg, D.A.⁵ Smith, E.A.⁶ O'Connor, O.A.⁷

24
- 33645277617
- Schluga P, Hartinger CG, Egger A, Reisner E, Galanski M, Jakupec MA, Keppler BK (2006) Dalton Trans 1796-1802
- (2006) Dalton Trans , pp. 1796-1802
- Schluga, P.¹ Hartinger, C.G.² Egger, A.³ Reisner, E.⁴ Galanski, M.⁵ Ma, J.⁶ Keppler, B.K.⁷

25
- 0030477371
- Synthesis, characterization and solution chemistry of trans-indazoliumtetrachlorobis(indazole)ruthenate(III), a new anticancer ruthenium complex. IR, UV, NMR, HPLC investigations and antitumor activity
- DOI 10.1155/MBD.1996.243
- K-G Lipponer E Vogel BK Keppler 1996 Metal Based Drugs 3 243 260 18472901 10.1155/MBD.1996.243 1:CAS:528:DyaK2sXnvVyq (Pubitemid 27030983)
- (1996) Metal-Based Drugs , vol.3 , Issue.5 , pp. 243-260
- Lipponer, K.-G.¹ Vogel, E.² Keppler, B.K.³

26
- 2942572700
- Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean?
- DOI 10.1038/sj.bjp.0705776
- B Halliwell M Whiteman 2004 Br J Pharmacol 142 231 255 15155533 10.1038/sj.bjp.0705776 1:CAS:528:DC%2BD2cXkvVyks7w%3D (Pubitemid 38746160)
- (2004) British Journal of Pharmacology , vol.142 , Issue.2 , pp. 231-255
- Halliwell, B.¹ Whiteman, M.²

27
- 57649208037
- 10.1039/b810481f 1:CAS:528:DC%2BD1cXhsFWisr%2FK
- AE Egger C Rappel MA Jakupec CG Hartinger P Heffeter BK Keppler 2009 J Anal At Spectrom 24 51 61 10.1039/b810481f 1:CAS:528:DC%2BD1cXhsFWisr%2FK
- (2009) J Anal at Spectrom , vol.24 , pp. 51-61
- Egger, A.E.¹ Rappel, C.² Jakupec, M.A.³ Hartinger, C.G.⁴ Heffeter, P.⁵ Keppler, B.K.⁶

28
- 33845884312
- Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands
- DOI 10.1124/mol.106.030726
- S Zorbas-Seifried MA Jakupec NV Kukushkin M Groessl CG Hartinger O Semenova H Zorbas VY Kukushkin BK Keppler 2007 Mol Pharmacol 71 357 365 17050805 10.1124/mol.106.030726 1:CAS:528:DC%2BD2sXit1Kjug%3D%3D (Pubitemid 46021005)
- (2007) Molecular Pharmacology , vol.71 , Issue.1 , pp. 357-365
- Zorbas-Seifried, S.¹ Jakupec, M.A.² Kukushkin, N.V.³ Groessl, M.⁴ Hartinger, C.G.⁵ Semenova, O.⁶ Zorbas, H.⁷ Kukushkin, V.Yu.⁸ Keppler, B.K.⁹

29
- 20244376291
- 9891494 1:CAS:528:DyaK1MXmvVaitA%3D%3D
- K Satoh Y Ida M Hosaka H Arakawa M Maeda M Ishihara S Kunii Y Kanda M Toguchi H Sakagami 1998 Anticancer Res 18 4371 4375 9891494 1:CAS:528: DyaK1MXmvVaitA%3D%3D
- (1998) Anticancer Res , vol.18 , pp. 4371-4375
- Satoh, K.¹ Ida, Y.² Hosaka, M.³ Arakawa, H.⁴ Maeda, M.⁵ Ishihara, M.⁶ Kunii, S.⁷ Kanda, Y.⁸ Toguchi, M.⁹ Sakagami, H.¹⁰

30
- 0030922112
- Effect of an iron-chelator on ascorbate-induced cytotoxicity
- DOI 10.1016/S0891-5849(96)00621-1, PII S0891584996006211
- H Sakagami K Satoh K Fukuchi K Gomi M Takeda 1997 Free Radic Biol Med 23 260 270 S0891584996006211 9199888 10.1016/S0891-5849(96)00621-1 1:CAS:528:DyaK2sXktFOgu7g%3D (Pubitemid 27276606)
- (1997) Free Radical Biology and Medicine , vol.23 , Issue.2 , pp. 260-270
- Sakagami, H.¹ Satoh, K.² Fukuchi, K.³ Gomi, K.⁴ Takeda, M.⁵

31
- 0006733083
- 1:CAS:528:DC%2BD3cXhvFShsLo%3D
- H Sakagami K Satoh Y Hakeda M Kumegawa 2000 Cell Mol Biol (Noisy-le-grand) 46 129 143 1:CAS:528:DC%2BD3cXhvFShsLo%3D
- (2000) Cell Mol Biol (Noisy-le-grand) , vol.46 , pp. 129-143
- Sakagami, H.¹ Satoh, K.² Hakeda, Y.³ Kumegawa, M.⁴

32
- 0031811065
- 9703900 1:CAS:528:DyaK1cXlsF2itLY%3D
- Y Amano H Sakagami T Tanaka Y Yamanaka Y Nishimoto M Yamaguchi M Takeda 1998 Anticancer Res 18 2503 2506 9703900 1:CAS:528:DyaK1cXlsF2itLY%3D
- (1998) Anticancer Res , vol.18 , pp. 2503-2506
- Amano, Y.¹ Sakagami, H.² Tanaka, T.³ Yamanaka, Y.⁴ Nishimoto, Y.⁵ Yamaguchi, M.⁶ Takeda, M.⁷

33
- 0033040739
- 10336883 1:CAS:528:DyaK1MXjsVOlurg%3D
- A Carr B Frei 1999 FASEB J 13 1007 1024 10336883 1:CAS:528: DyaK1MXjsVOlurg%3D
- (1999) FASEB J , vol.13 , pp. 1007-1024
- Carr, A.¹ Frei, B.²

34
- 0001218860
- 2762330 10.1073/pnas.86.16.6377 1:CAS:528:DyaL1MXltlWrsb4%3D
- B Frei L England BN Ames 1989 Proc Natl Acad Sci USA 86 6377 6381 2762330 10.1073/pnas.86.16.6377 1:CAS:528:DyaL1MXltlWrsb4%3D
- (1989) Proc Natl Acad Sci USA , vol.86 , pp. 6377-6381
- Frei, B.¹ England, L.² Ames, B.N.³

35
- 77949538182
- doi: 10.1017/S0007114509992285
- Bevan RJ, Mistry N, Patel PR, Halligan EP, Dove R, Lunec J (2010) Br J Nutrit 103:686-695. doi: 10.1017/S0007114509992285
- (2010) Br J Nutrit , vol.103 , pp. 686-695
- Bevan, R.J.¹ Mistry, N.² Patel, P.R.³ Halligan, E.P.⁴ Dove, R.⁵ Lunec, J.⁶

36
- 0036161069
- Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A
- DOI 10.1016/S0959-8049(01)00389-6, PII S0959804901003896
- G Sava A Bergamo S Zorzet B Gava C Casarsa M Cocchietto A Furlani V Scarcia B Serli E Iengo E Alessio G Mestroni 2002 Eur J Cancer 38 427 435 11818210 10.1016/S0959-8049(01)00389-6 1:CAS:528:DC%2BD38XovFSgsw%3D%3D (Pubitemid 34123316)
- (2002) European Journal of Cancer , vol.38 , Issue.3 , pp. 427-435
- Sava, G.¹ Bergamo, A.² Zorzet, S.³ Gava, B.⁴ Casarsa, C.⁵ Cocchietto, M.⁶ Furlani, A.⁷ Scarcia, V.⁸ Serli, B.⁹ Iengo, E.¹⁰ Alessio, E.¹¹ Mestroni, G.¹²

37
- 19944430023
- Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole) ruthenate (III)] (FFC14A)
- DOI 10.1124/jpet.104.073395
- P Heffeter M Pongratz E Steiner P Chiba MA Jakupec L Elbling B Marian W Koerner F Sevelda M Micksche BK Keppler W Berger 2005 J Pharmacol Exp Ther 312 281 289 15331656 10.1124/jpet.104.073395 1:CAS:528:DC%2BD2MXhtVWmtbs%3D (Pubitemid 40096479)
- (2005) Journal of Pharmacology and Experimental Therapeutics , vol.312 , Issue.1 , pp. 281-289
- Heffeter, P.¹ Pongratz, M.² Steiner, E.³ Chiba, P.⁴ Jakupec, M.A.⁵ Elbling, L.⁶ Marian, B.⁷ Korner, W.⁸ Sevelda, F.⁹ Micksche, M.¹⁰ Keppler, B.K.¹¹ Berger, W.¹²

38
- 34447517227
- Probing the stability of serum protein-ruthenium(III) drug adducts in the presence of extracellular reductants using CE
- DOI 10.1002/elps.200600707
- AR Timerbaev LS Foteeva AV Rudnev JK Abramski K Polec-Pawlak CG Hartinger M Jarosz BK Keppler 2007 Electrophoresis 28 2235 2240 17557359 10.1002/elps.200600707 1:CAS:528:DC%2BD2sXotVyrtLs%3D (Pubitemid 47065151)
- (2007) Electrophoresis , vol.28 , Issue.13 , pp. 2235-2240
- Timerbaev, A.R.¹ Foteeva, L.S.² Rudnev, A.V.³ Abramski, J.K.⁴ Polec-Pawlak, K.⁵ Hartinger, C.G.⁶ Jarosz, M.⁷ Keppler, B.K.⁸

39
- 2442449173
- 2] and serum proteins
- DOI 10.1016/j.jinorgbio.2004.04.002, PII S0162013404001060
- F Piccioli S Sabatini L Messori P Orioli CG Hartinger BK Keppler 2004 J Inorg Biochem 98 1135 1142 15149825 10.1016/j.jinorgbio.2004.04.002 1:CAS:528:DC%2BD2cXktVCmt7k%3D (Pubitemid 38638512)
- (2004) Journal of Inorganic Biochemistry , vol.98 , Issue.6 , pp. 1135-1142
- Piccioli, F.¹ Sabatini, S.² Messori, L.³ Orioli, P.⁴ Hartinger, Ch.G.⁵ Keppler, B.K.⁶

40
- 77949275871
- Cetinbas N, Webb MI, Dubland JA, Walsby CJ (2010) J Biol Inorg Chem 15:131-145
- (2010) J Biol Inorg Chem , vol.15 , pp. 131-145
- Cetinbas, N.¹ Webb, M.I.² Dubland, J.A.³ Walsby, C.J.⁴

41
- 0024399787
- Quantitative determination of water- and lipid-soluble antioxidants in neoplastic and non-neoplastic human breast tissue
- DOI 10.1002/ijc.2910430634
- H Langemann J Torhorst A Kabiersch W Krenger CG Honegger 1989 Int J Cancer 43 1169 1173 2732005 10.1002/ijc.2910430634 1:CAS:528:DyaL1MXkslGmur0%3D (Pubitemid 19158054)
- (1989) International Journal of Cancer , vol.43 , Issue.6 , pp. 1169-1173
- Langemann, H.¹ Torhorst, J.² Kabiersch, A.³ Krenger, W.⁴ Honegger, C.G.⁵

42
- 0033567885
- 10493506 1:CAS:528:DyaK1MXmtVKksb0%3D
- DB Agus JC Vera DW Golde 1999 Cancer Res 59 4555 4558 10493506 1:CAS:528:DyaK1MXmtVKksb0%3D
- (1999) Cancer Res , vol.59 , pp. 4555-4558
- Agus, D.B.¹ Vera, J.C.² Golde, D.W.³

43
- 77953293948
- Heffeter P, Boeck K, Atil B, Hoda MAR, Koerner W, Bartel C, Jungwirth U, Keppler BK, Micksche M, Berger W, Koellensperger G (2010) J Biol Inorg Chem 15:737-748
- (2010) J Biol Inorg Chem , vol.15 , pp. 737-748
- Heffeter, P.¹ Boeck, K.² Atil, B.³ Mar, H.⁴ Koerner, W.⁵ Bartel, C.⁶ Jungwirth, U.⁷ Keppler, B.K.⁸ Micksche, M.⁹ Berger, W.¹⁰ Koellensperger, G.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.